Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics, and Hematopoietic Stem Cell Mobilization of TG-0054 Alone or in Combination With G-CSF in Patients With Multiple Myeloma, Non-Hodgkin Lymphoma or Hodgkin Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating TG-0054 alone or with G-CSF in multiple myeloma and lymphomas; completed with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Multiple Myeloma
• Non-hodgkin Lymphoma

Drugs mentioned

• G-CSF (granulocyte colony-stimulating factor)
• TG-0054

Snippet

Sponsor: GPCR Therapeutics, Inc. | Conditions: Multiple Myeloma, Non-hodgkin's Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2015-01-08